These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. [Avascular necrosis of the bone in patients with HIV infection: an emergent problem]. Moreno-Cuerda VJ; Morales M; Tamargo L; Rubio R; Pulido F Rev Clin Esp; 2006 Sep; 206(8):392-6. PubMed ID: 16863626 [TBL] [Abstract][Full Text] [Related]
9. HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed. Zolopa AR; Shafer RW; Warford A; Montoya JG; Hsu P; Katzenstein D; Merigan TC; Efron B Ann Intern Med; 1999 Dec; 131(11):813-21. PubMed ID: 10610625 [TBL] [Abstract][Full Text] [Related]
10. Double boosted protease inhibitors, saquinavir, and lopinavir/ritonavir, in nucleoside pretreated children at 48 weeks. Kosalaraksa P; Bunupuradah T; Engchanil C; Boonrak P; Intasan J; Lumbiganon P; Burger D; Ruxrungtham K; Schutz M; Ananworanich J; Pediatr Infect Dis J; 2008 Jul; 27(7):623-8. PubMed ID: 18520443 [TBL] [Abstract][Full Text] [Related]
11. Antiretroviral treatment and osteonecrosis in patients of the Swiss HIV Cohort Study: a nested case-control study. Hasse B; Ledergerber B; Egger M; Flepp M; Bachmann S; Bernasconi E; Egger M; Guyot S; Hirschel B; Weber R; Günthard HF; AIDS Res Hum Retroviruses; 2004 Sep; 20(9):909-15. PubMed ID: 15597520 [TBL] [Abstract][Full Text] [Related]
12. [Osteonecrosis in HIV-infected patients and its correlation with highly active antiretroviral therapy (HAART)]. Calza L; Manfredi R; Chiodo F Presse Med; 2003 Apr; 32(13 Pt 1):595-8. PubMed ID: 12714913 [TBL] [Abstract][Full Text] [Related]
13. Changes in CD4+ cell count and the risk of opportunistic infection or death after highly active antiretroviral treatment. Groupe d'Epidémiologie Clinique du SIDA en Aquitaine. Chêne G; Binquet C; Moreau JF; Neau D; Pellegrin I; Malvy D; Ceccaldi J; Lacoste D; Dabis F AIDS; 1998 Dec; 12(17):2313-20. PubMed ID: 9863874 [TBL] [Abstract][Full Text] [Related]
14. Virological treatment failure of protease inhibitor therapy in an unselected cohort of HIV-infected patients. Fätkenheuer G; Theisen A; Rockstroh J; Grabow T; Wicke C; Becker K; Wieland U; Pfister H; Reiser M; Hegener P; Franzen C; Schwenk A; Salzberger B AIDS; 1997 Nov; 11(14):F113-6. PubMed ID: 9386799 [TBL] [Abstract][Full Text] [Related]
15. Osteonecrosis in six HIV-infected patients receiving highly active antiretroviral therapy. Molia AC; Strady C; Rouger C; Beguinot IM; Berger JL; Trenque TC Ann Pharmacother; 2004 Dec; 38(12):2050-4. PubMed ID: 15507502 [TBL] [Abstract][Full Text] [Related]
16. Symptomatic bone disorders in HIV-infected patients: incidence in the Aquitaine cohort (1999-2002). Martin K; Lawson-Ayayi S; Miremont-Salamé G; Blaizeau MJ; Balestre E; Lacoste D; Ragnaud JM; Malvy D; Dupon M; Mercié P; Schaeverbeke T; Haramburu F; Dabis F; HIV Med; 2004 Nov; 5(6):421-6. PubMed ID: 15544694 [TBL] [Abstract][Full Text] [Related]